nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ALB—lung cancer	0.149	1	CbGaD
Furosemide—PGD—Methotrexate—lung cancer	0.11	0.226	CbGbCtD
Furosemide—ALB—Gefitinib—lung cancer	0.0398	0.0818	CbGbCtD
Furosemide—ABCC2—Paclitaxel—lung cancer	0.0346	0.0711	CbGbCtD
Furosemide—ABCC2—Irinotecan—lung cancer	0.0341	0.0701	CbGbCtD
Furosemide—SLC22A11—Methotrexate—lung cancer	0.0326	0.067	CbGbCtD
Furosemide—ABCC2—Vinblastine—lung cancer	0.0303	0.0623	CbGbCtD
Furosemide—ABCC2—Cisplatin—lung cancer	0.0278	0.0572	CbGbCtD
Furosemide—ABCC2—Etoposide—lung cancer	0.0273	0.0562	CbGbCtD
Furosemide—ABCC2—Docetaxel—lung cancer	0.025	0.0514	CbGbCtD
Furosemide—ALB—Erlotinib—lung cancer	0.0235	0.0484	CbGbCtD
Furosemide—ALB—Irinotecan—lung cancer	0.0213	0.0437	CbGbCtD
Furosemide—SLC22A8—Methotrexate—lung cancer	0.019	0.039	CbGbCtD
Furosemide—ABCC2—Doxorubicin—lung cancer	0.0186	0.0383	CbGbCtD
Furosemide—ABCC2—Methotrexate—lung cancer	0.0181	0.0371	CbGbCtD
Furosemide—SLC22A6—Methotrexate—lung cancer	0.0132	0.0272	CbGbCtD
Furosemide—ALB—Methotrexate—lung cancer	0.0113	0.0231	CbGbCtD
Furosemide—PGD—mammary gland—lung cancer	0.00217	0.046	CbGeAlD
Furosemide—CA5B—mammary gland—lung cancer	0.00205	0.0436	CbGeAlD
Furosemide—CA7—trachea—lung cancer	0.00173	0.0368	CbGeAlD
Furosemide—SLCO2A1—respiratory system—lung cancer	0.00162	0.0344	CbGeAlD
Furosemide—ALB—mammary gland—lung cancer	0.00159	0.0338	CbGeAlD
Furosemide—CA12—respiratory system—lung cancer	0.00152	0.0324	CbGeAlD
Furosemide—SLC12A1—epithelium—lung cancer	0.00147	0.0312	CbGeAlD
Furosemide—PGD—respiratory system—lung cancer	0.00144	0.0307	CbGeAlD
Furosemide—CA14—cardiac atrium—lung cancer	0.00136	0.0288	CbGeAlD
Furosemide—SLCO2A1—epithelium—lung cancer	0.00135	0.0288	CbGeAlD
Furosemide—SLCO2A1—bronchus—lung cancer	0.00133	0.0283	CbGeAlD
Furosemide—CA1—respiratory system—lung cancer	0.00121	0.0257	CbGeAlD
Furosemide—SLCO2A1—trachea—lung cancer	0.0012	0.0254	CbGeAlD
Furosemide—PGD—bronchus—lung cancer	0.00119	0.0252	CbGeAlD
Furosemide—SLC22A5—mammary gland—lung cancer	0.00116	0.0245	CbGeAlD
Furosemide—CA12—trachea—lung cancer	0.00113	0.0239	CbGeAlD
Furosemide—SLCO2A1—cardiac atrium—lung cancer	0.00112	0.0239	CbGeAlD
Furosemide—PGD—trachea—lung cancer	0.00107	0.0227	CbGeAlD
Furosemide—PGD—cardiac atrium—lung cancer	0.001	0.0213	CbGeAlD
Furosemide—CA5B—cardiac atrium—lung cancer	0.000949	0.0202	CbGeAlD
Furosemide—CA4—respiratory system—lung cancer	0.000944	0.0201	CbGeAlD
Furosemide—SLCO2A1—lung—lung cancer	0.00086	0.0183	CbGeAlD
Furosemide—PGD—bone marrow—lung cancer	0.000846	0.018	CbGeAlD
Furosemide—CA12—lung—lung cancer	0.000809	0.0172	CbGeAlD
Furosemide—CA2—respiratory system—lung cancer	0.000783	0.0166	CbGeAlD
Furosemide—SLC22A5—respiratory system—lung cancer	0.00077	0.0164	CbGeAlD
Furosemide—PGD—lung—lung cancer	0.000766	0.0163	CbGeAlD
Furosemide—CA5B—lung—lung cancer	0.000726	0.0154	CbGeAlD
Furosemide—CA1—bone marrow—lung cancer	0.000708	0.015	CbGeAlD
Furosemide—CA4—trachea—lung cancer	0.000697	0.0148	CbGeAlD
Furosemide—CA4—cardiac atrium—lung cancer	0.000655	0.0139	CbGeAlD
Furosemide—CA2—epithelium—lung cancer	0.000654	0.0139	CbGeAlD
Furosemide—CA2—bronchus—lung cancer	0.000644	0.0137	CbGeAlD
Furosemide—CA1—lung—lung cancer	0.000641	0.0136	CbGeAlD
Furosemide—SLC22A5—bronchus—lung cancer	0.000634	0.0135	CbGeAlD
Furosemide—SLCO2A1—lymph node—lung cancer	0.000588	0.0125	CbGeAlD
Furosemide—CA2—trachea—lung cancer	0.000578	0.0123	CbGeAlD
Furosemide—SLC22A5—trachea—lung cancer	0.000569	0.0121	CbGeAlD
Furosemide—CA4—bone marrow—lung cancer	0.000553	0.0118	CbGeAlD
Furosemide—CA2—cardiac atrium—lung cancer	0.000543	0.0115	CbGeAlD
Furosemide—SLC22A5—cardiac atrium—lung cancer	0.000535	0.0114	CbGeAlD
Furosemide—PGD—lymph node—lung cancer	0.000524	0.0111	CbGeAlD
Furosemide—CA4—lung—lung cancer	0.000501	0.0106	CbGeAlD
Furosemide—CA5B—lymph node—lung cancer	0.000497	0.0106	CbGeAlD
Furosemide—CA2—bone marrow—lung cancer	0.000459	0.00975	CbGeAlD
Furosemide—CA1—lymph node—lung cancer	0.000439	0.00932	CbGeAlD
Furosemide—CA2—lung—lung cancer	0.000416	0.00883	CbGeAlD
Furosemide—SLC22A5—lung—lung cancer	0.000409	0.00869	CbGeAlD
Furosemide—ALB—lymph node—lung cancer	0.000385	0.00818	CbGeAlD
Furosemide—ABCC2—lymph node—lung cancer	0.000361	0.00767	CbGeAlD
Furosemide—CA4—lymph node—lung cancer	0.000343	0.00728	CbGeAlD
Furosemide—CA2—lymph node—lung cancer	0.000284	0.00604	CbGeAlD
Furosemide—SLC22A5—lymph node—lung cancer	0.00028	0.00594	CbGeAlD
Furosemide—Paraesthesia—Cisplatin—lung cancer	0.000125	0.000587	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—lung cancer	0.000125	0.000586	CcSEcCtD
Furosemide—Muscle spasms—Docetaxel—lung cancer	0.000125	0.000586	CcSEcCtD
Furosemide—Skin disorder—Etoposide—lung cancer	0.000124	0.000581	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—lung cancer	0.000123	0.000579	CcSEcCtD
Furosemide—Feeling abnormal—Gemcitabine—lung cancer	0.000123	0.000577	CcSEcCtD
Furosemide—Shock—Paclitaxel—lung cancer	0.000123	0.000577	CcSEcCtD
Furosemide—Dizziness—Vinorelbine—lung cancer	0.000123	0.000577	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—lung cancer	0.000123	0.000577	CcSEcCtD
Furosemide—Nervous system disorder—Paclitaxel—lung cancer	0.000122	0.000575	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—lung cancer	0.000122	0.000575	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—lung cancer	0.000122	0.000575	CcSEcCtD
Furosemide—Thrombocytopenia—Paclitaxel—lung cancer	0.000122	0.000574	CcSEcCtD
Furosemide—Anorexia—Etoposide—lung cancer	0.000121	0.00057	CcSEcCtD
Furosemide—Skin disorder—Paclitaxel—lung cancer	0.000121	0.00057	CcSEcCtD
Furosemide—Abdominal pain—Irinotecan—lung cancer	0.000121	0.000569	CcSEcCtD
Furosemide—Body temperature increased—Irinotecan—lung cancer	0.000121	0.000569	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000121	0.000569	CcSEcCtD
Furosemide—Decreased appetite—Cisplatin—lung cancer	0.000121	0.000568	CcSEcCtD
Furosemide—Hyperhidrosis—Paclitaxel—lung cancer	0.000121	0.000567	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cisplatin—lung cancer	0.00012	0.000564	CcSEcCtD
Furosemide—Anaemia—Docetaxel—lung cancer	0.00012	0.000563	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—lung cancer	0.000119	0.000562	CcSEcCtD
Furosemide—Anorexia—Paclitaxel—lung cancer	0.000119	0.000559	CcSEcCtD
Furosemide—Hypotension—Etoposide—lung cancer	0.000119	0.000559	CcSEcCtD
Furosemide—Pain—Cisplatin—lung cancer	0.000119	0.000559	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000118	0.000557	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—lung cancer	0.000118	0.000557	CcSEcCtD
Furosemide—Vomiting—Vinorelbine—lung cancer	0.000118	0.000555	CcSEcCtD
Furosemide—Body temperature increased—Gemcitabine—lung cancer	0.000118	0.000554	CcSEcCtD
Furosemide—Renal failure—Methotrexate—lung cancer	0.000117	0.000552	CcSEcCtD
Furosemide—Rash—Vinorelbine—lung cancer	0.000117	0.00055	CcSEcCtD
Furosemide—Dermatitis—Vinorelbine—lung cancer	0.000117	0.00055	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—lung cancer	0.000117	0.000549	CcSEcCtD
Furosemide—Hypotension—Paclitaxel—lung cancer	0.000117	0.000548	CcSEcCtD
Furosemide—Headache—Vinorelbine—lung cancer	0.000116	0.000546	CcSEcCtD
Furosemide—Leukopenia—Docetaxel—lung cancer	0.000116	0.000545	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—lung cancer	0.000115	0.00054	CcSEcCtD
Furosemide—Sweating—Methotrexate—lung cancer	0.000115	0.000539	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—lung cancer	0.000114	0.000538	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—lung cancer	0.000114	0.000537	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—lung cancer	0.000114	0.000535	CcSEcCtD
Furosemide—Somnolence—Etoposide—lung cancer	0.000113	0.000532	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—lung cancer	0.000113	0.000532	CcSEcCtD
Furosemide—Hypersensitivity—Irinotecan—lung cancer	0.000113	0.00053	CcSEcCtD
Furosemide—Paraesthesia—Paclitaxel—lung cancer	0.000112	0.000527	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—lung cancer	0.000112	0.000524	CcSEcCtD
Furosemide—Somnolence—Paclitaxel—lung cancer	0.000111	0.000522	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—lung cancer	0.000111	0.00052	CcSEcCtD
Furosemide—Nausea—Vinorelbine—lung cancer	0.00011	0.000518	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—lung cancer	0.00011	0.000517	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—lung cancer	0.00011	0.000516	CcSEcCtD
Furosemide—Asthenia—Irinotecan—lung cancer	0.00011	0.000516	CcSEcCtD
Furosemide—Fatigue—Etoposide—lung cancer	0.00011	0.000516	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00011	0.000515	CcSEcCtD
Furosemide—Pain—Etoposide—lung cancer	0.000109	0.000512	CcSEcCtD
Furosemide—Constipation—Etoposide—lung cancer	0.000109	0.000512	CcSEcCtD
Furosemide—Decreased appetite—Paclitaxel—lung cancer	0.000108	0.00051	CcSEcCtD
Furosemide—Dry mouth—Docetaxel—lung cancer	0.000108	0.000507	CcSEcCtD
Furosemide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000108	0.000507	CcSEcCtD
Furosemide—Fatigue—Paclitaxel—lung cancer	0.000108	0.000506	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—lung cancer	0.000107	0.000504	CcSEcCtD
Furosemide—Asthenia—Gemcitabine—lung cancer	0.000107	0.000503	CcSEcCtD
Furosemide—Constipation—Paclitaxel—lung cancer	0.000107	0.000502	CcSEcCtD
Furosemide—Pain—Paclitaxel—lung cancer	0.000107	0.000502	CcSEcCtD
Furosemide—Confusional state—Docetaxel—lung cancer	0.000107	0.000501	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—lung cancer	0.000106	0.000498	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—lung cancer	0.000106	0.000498	CcSEcCtD
Furosemide—Anaphylactic shock—Docetaxel—lung cancer	0.000106	0.000497	CcSEcCtD
Furosemide—Pruritus—Gemcitabine—lung cancer	0.000105	0.000496	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—lung cancer	0.000105	0.000495	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—lung cancer	0.000105	0.000493	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—lung cancer	0.000105	0.000492	CcSEcCtD
Furosemide—Diarrhoea—Irinotecan—lung cancer	0.000105	0.000492	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—lung cancer	0.000104	0.000489	CcSEcCtD
Furosemide—Shock—Docetaxel—lung cancer	0.000104	0.000489	CcSEcCtD
Furosemide—Nervous system disorder—Docetaxel—lung cancer	0.000104	0.000488	CcSEcCtD
Furosemide—Thrombocytopenia—Docetaxel—lung cancer	0.000104	0.000487	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—lung cancer	0.000103	0.000487	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—lung cancer	0.000103	0.000486	CcSEcCtD
Furosemide—Feeling abnormal—Paclitaxel—lung cancer	0.000103	0.000484	CcSEcCtD
Furosemide—Skin disorder—Docetaxel—lung cancer	0.000103	0.000483	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000103	0.000482	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—lung cancer	0.000102	0.000481	CcSEcCtD
Furosemide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000102	0.00048	CcSEcCtD
Furosemide—Diarrhoea—Gemcitabine—lung cancer	0.000102	0.000479	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—lung cancer	0.000102	0.000478	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—lung cancer	0.000101	0.000477	CcSEcCtD
Furosemide—Dizziness—Irinotecan—lung cancer	0.000101	0.000476	CcSEcCtD
Furosemide—Urticaria—Etoposide—lung cancer	0.000101	0.000475	CcSEcCtD
Furosemide—Anorexia—Docetaxel—lung cancer	0.000101	0.000474	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—lung cancer	0.000101	0.000473	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—lung cancer	0.000101	0.000473	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—lung cancer	0.0001	0.000471	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—lung cancer	0.0001	0.00047	CcSEcCtD
Furosemide—Asthenia—Cisplatin—lung cancer	9.96e-05	0.000469	CcSEcCtD
Furosemide—Sweating—Doxorubicin—lung cancer	9.92e-05	0.000467	CcSEcCtD
Furosemide—Urticaria—Paclitaxel—lung cancer	9.91e-05	0.000466	CcSEcCtD
Furosemide—Hypotension—Docetaxel—lung cancer	9.88e-05	0.000465	CcSEcCtD
Furosemide—Abdominal pain—Paclitaxel—lung cancer	9.86e-05	0.000464	CcSEcCtD
Furosemide—Body temperature increased—Paclitaxel—lung cancer	9.86e-05	0.000464	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—lung cancer	9.78e-05	0.00046	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—lung cancer	9.73e-05	0.000458	CcSEcCtD
Furosemide—Vomiting—Irinotecan—lung cancer	9.72e-05	0.000457	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—lung cancer	9.69e-05	0.000456	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—lung cancer	9.65e-05	0.000454	CcSEcCtD
Furosemide—Rash—Irinotecan—lung cancer	9.64e-05	0.000454	CcSEcCtD
Furosemide—Dermatitis—Irinotecan—lung cancer	9.63e-05	0.000453	CcSEcCtD
Furosemide—Headache—Irinotecan—lung cancer	9.58e-05	0.000451	CcSEcCtD
Furosemide—Diarrhoea—Cisplatin—lung cancer	9.5e-05	0.000447	CcSEcCtD
Furosemide—Paraesthesia—Docetaxel—lung cancer	9.49e-05	0.000447	CcSEcCtD
Furosemide—Vomiting—Gemcitabine—lung cancer	9.47e-05	0.000446	CcSEcCtD
Furosemide—Somnolence—Docetaxel—lung cancer	9.4e-05	0.000442	CcSEcCtD
Furosemide—Rash—Gemcitabine—lung cancer	9.39e-05	0.000442	CcSEcCtD
Furosemide—Dermatitis—Gemcitabine—lung cancer	9.39e-05	0.000441	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—lung cancer	9.37e-05	0.000441	CcSEcCtD
Furosemide—Erythema—Methotrexate—lung cancer	9.34e-05	0.000439	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—lung cancer	9.34e-05	0.000439	CcSEcCtD
Furosemide—Headache—Gemcitabine—lung cancer	9.33e-05	0.000439	CcSEcCtD
Furosemide—Decreased appetite—Docetaxel—lung cancer	9.19e-05	0.000432	CcSEcCtD
Furosemide—Hypersensitivity—Paclitaxel—lung cancer	9.19e-05	0.000432	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—lung cancer	9.17e-05	0.000431	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—lung cancer	9.14e-05	0.00043	CcSEcCtD
Furosemide—Gastrointestinal disorder—Docetaxel—lung cancer	9.13e-05	0.000429	CcSEcCtD
Furosemide—Asthenia—Etoposide—lung cancer	9.13e-05	0.000429	CcSEcCtD
Furosemide—Fatigue—Docetaxel—lung cancer	9.12e-05	0.000429	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—lung cancer	9.1e-05	0.000428	CcSEcCtD
Furosemide—Nausea—Irinotecan—lung cancer	9.08e-05	0.000427	CcSEcCtD
Furosemide—Constipation—Docetaxel—lung cancer	9.04e-05	0.000425	CcSEcCtD
Furosemide—Pain—Docetaxel—lung cancer	9.04e-05	0.000425	CcSEcCtD
Furosemide—Pruritus—Etoposide—lung cancer	9e-05	0.000423	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—lung cancer	8.95e-05	0.000421	CcSEcCtD
Furosemide—Asthenia—Paclitaxel—lung cancer	8.95e-05	0.000421	CcSEcCtD
Furosemide—Nausea—Gemcitabine—lung cancer	8.85e-05	0.000416	CcSEcCtD
Furosemide—Vomiting—Cisplatin—lung cancer	8.83e-05	0.000415	CcSEcCtD
Furosemide—Pruritus—Paclitaxel—lung cancer	8.83e-05	0.000415	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—lung cancer	8.8e-05	0.000414	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—lung cancer	8.78e-05	0.000413	CcSEcCtD
Furosemide—Rash—Cisplatin—lung cancer	8.76e-05	0.000412	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—lung cancer	8.75e-05	0.000411	CcSEcCtD
Furosemide—Feeling abnormal—Docetaxel—lung cancer	8.71e-05	0.00041	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—lung cancer	8.7e-05	0.000409	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—lung cancer	8.68e-05	0.000408	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—lung cancer	8.66e-05	0.000407	CcSEcCtD
Furosemide—Gastrointestinal pain—Docetaxel—lung cancer	8.65e-05	0.000407	CcSEcCtD
Furosemide—Anaemia—Methotrexate—lung cancer	8.63e-05	0.000406	CcSEcCtD
Furosemide—Diarrhoea—Paclitaxel—lung cancer	8.53e-05	0.000401	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—lung cancer	8.43e-05	0.000396	CcSEcCtD
Furosemide—Dizziness—Etoposide—lung cancer	8.41e-05	0.000396	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—lung cancer	8.39e-05	0.000395	CcSEcCtD
Furosemide—Vertigo—Methotrexate—lung cancer	8.39e-05	0.000395	CcSEcCtD
Furosemide—Abdominal pain—Docetaxel—lung cancer	8.36e-05	0.000393	CcSEcCtD
Furosemide—Body temperature increased—Docetaxel—lung cancer	8.36e-05	0.000393	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—lung cancer	8.36e-05	0.000393	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—lung cancer	8.3e-05	0.00039	CcSEcCtD
Furosemide—Dizziness—Paclitaxel—lung cancer	8.25e-05	0.000388	CcSEcCtD
Furosemide—Nausea—Cisplatin—lung cancer	8.25e-05	0.000388	CcSEcCtD
Furosemide—Vomiting—Etoposide—lung cancer	8.09e-05	0.00038	CcSEcCtD
Furosemide—Erythema—Doxorubicin—lung cancer	8.09e-05	0.00038	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—lung cancer	8.09e-05	0.00038	CcSEcCtD
Furosemide—Rash—Etoposide—lung cancer	8.02e-05	0.000377	CcSEcCtD
Furosemide—Dermatitis—Etoposide—lung cancer	8.01e-05	0.000377	CcSEcCtD
Furosemide—Headache—Etoposide—lung cancer	7.97e-05	0.000375	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—lung cancer	7.97e-05	0.000375	CcSEcCtD
Furosemide—Vomiting—Paclitaxel—lung cancer	7.93e-05	0.000373	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—lung cancer	7.92e-05	0.000372	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.89e-05	0.000371	CcSEcCtD
Furosemide—Rash—Paclitaxel—lung cancer	7.86e-05	0.00037	CcSEcCtD
Furosemide—Dermatitis—Paclitaxel—lung cancer	7.86e-05	0.00037	CcSEcCtD
Furosemide—Headache—Paclitaxel—lung cancer	7.81e-05	0.000368	CcSEcCtD
Furosemide—Hypersensitivity—Docetaxel—lung cancer	7.79e-05	0.000366	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—lung cancer	7.77e-05	0.000366	CcSEcCtD
Furosemide—Confusional state—Methotrexate—lung cancer	7.68e-05	0.000361	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—lung cancer	7.62e-05	0.000358	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—lung cancer	7.62e-05	0.000358	CcSEcCtD
Furosemide—Asthenia—Docetaxel—lung cancer	7.59e-05	0.000357	CcSEcCtD
Furosemide—Nausea—Etoposide—lung cancer	7.56e-05	0.000355	CcSEcCtD
Furosemide—Pruritus—Docetaxel—lung cancer	7.48e-05	0.000352	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—lung cancer	7.47e-05	0.000352	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—lung cancer	7.47e-05	0.000351	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—lung cancer	7.46e-05	0.000351	CcSEcCtD
Furosemide—Agitation—Doxorubicin—lung cancer	7.43e-05	0.000349	CcSEcCtD
Furosemide—Nausea—Paclitaxel—lung cancer	7.41e-05	0.000349	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—lung cancer	7.4e-05	0.000348	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—lung cancer	7.37e-05	0.000347	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—lung cancer	7.26e-05	0.000342	CcSEcCtD
Furosemide—Anorexia—Methotrexate—lung cancer	7.26e-05	0.000342	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—lung cancer	7.24e-05	0.00034	CcSEcCtD
Furosemide—Diarrhoea—Docetaxel—lung cancer	7.23e-05	0.00034	CcSEcCtD
Furosemide—Hypotension—Methotrexate—lung cancer	7.12e-05	0.000335	CcSEcCtD
Furosemide—Dizziness—Docetaxel—lung cancer	6.99e-05	0.000329	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—lung cancer	6.84e-05	0.000322	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.84e-05	0.000322	CcSEcCtD
Furosemide—Somnolence—Methotrexate—lung cancer	6.77e-05	0.000319	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—lung cancer	6.73e-05	0.000317	CcSEcCtD
Furosemide—Vomiting—Docetaxel—lung cancer	6.72e-05	0.000316	CcSEcCtD
Furosemide—Rash—Docetaxel—lung cancer	6.67e-05	0.000314	CcSEcCtD
Furosemide—Dermatitis—Docetaxel—lung cancer	6.66e-05	0.000313	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—lung cancer	6.65e-05	0.000313	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—lung cancer	6.62e-05	0.000312	CcSEcCtD
Furosemide—Headache—Docetaxel—lung cancer	6.62e-05	0.000312	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—lung cancer	6.6e-05	0.00031	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—lung cancer	6.58e-05	0.000309	CcSEcCtD
Furosemide—Fatigue—Methotrexate—lung cancer	6.57e-05	0.000309	CcSEcCtD
Furosemide—Pain—Methotrexate—lung cancer	6.52e-05	0.000307	CcSEcCtD
Furosemide—Shock—Doxorubicin—lung cancer	6.49e-05	0.000305	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—lung cancer	6.47e-05	0.000304	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—lung cancer	6.46e-05	0.000304	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—lung cancer	6.41e-05	0.000301	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—lung cancer	6.38e-05	0.0003	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—lung cancer	6.29e-05	0.000296	CcSEcCtD
Furosemide—Nausea—Docetaxel—lung cancer	6.28e-05	0.000295	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—lung cancer	6.28e-05	0.000295	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—lung cancer	6.23e-05	0.000293	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—lung cancer	6.17e-05	0.00029	CcSEcCtD
Furosemide—Urticaria—Methotrexate—lung cancer	6.05e-05	0.000285	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—lung cancer	6.02e-05	0.000283	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—lung cancer	6.02e-05	0.000283	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—lung cancer	5.93e-05	0.000279	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—lung cancer	5.87e-05	0.000276	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—lung cancer	5.74e-05	0.00027	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—lung cancer	5.7e-05	0.000268	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—lung cancer	5.69e-05	0.000268	CcSEcCtD
Furosemide—Pain—Doxorubicin—lung cancer	5.64e-05	0.000265	CcSEcCtD
Furosemide—Constipation—Doxorubicin—lung cancer	5.64e-05	0.000265	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—lung cancer	5.61e-05	0.000264	CcSEcCtD
Furosemide—Asthenia—Methotrexate—lung cancer	5.47e-05	0.000257	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—lung cancer	5.44e-05	0.000256	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—lung cancer	5.4e-05	0.000254	CcSEcCtD
Furosemide—Pruritus—Methotrexate—lung cancer	5.39e-05	0.000254	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—lung cancer	5.24e-05	0.000247	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—lung cancer	5.22e-05	0.000245	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—lung cancer	5.22e-05	0.000245	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—lung cancer	5.21e-05	0.000245	CcSEcCtD
Furosemide—Dizziness—Methotrexate—lung cancer	5.04e-05	0.000237	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—lung cancer	4.86e-05	0.000229	CcSEcCtD
Furosemide—Vomiting—Methotrexate—lung cancer	4.85e-05	0.000228	CcSEcCtD
Furosemide—Rash—Methotrexate—lung cancer	4.8e-05	0.000226	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—lung cancer	4.8e-05	0.000226	CcSEcCtD
Furosemide—Headache—Methotrexate—lung cancer	4.77e-05	0.000225	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—lung cancer	4.73e-05	0.000223	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—lung cancer	4.67e-05	0.00022	CcSEcCtD
Furosemide—Nausea—Methotrexate—lung cancer	4.53e-05	0.000213	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—lung cancer	4.51e-05	0.000212	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—lung cancer	4.36e-05	0.000205	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—lung cancer	4.2e-05	0.000197	CcSEcCtD
Furosemide—Rash—Doxorubicin—lung cancer	4.16e-05	0.000196	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—lung cancer	4.16e-05	0.000196	CcSEcCtD
Furosemide—Headache—Doxorubicin—lung cancer	4.13e-05	0.000194	CcSEcCtD
Furosemide—Nausea—Doxorubicin—lung cancer	3.92e-05	0.000184	CcSEcCtD
Furosemide—CA5A—Metabolism—ALB—lung cancer	2.16e-05	0.000207	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—lung cancer	2.16e-05	0.000207	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IRF1—lung cancer	2.16e-05	0.000207	CbGpPWpGaD
Furosemide—CA7—Metabolism—CREBBP—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CREBBP—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLBD1—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Furosemide—CA1—Metabolism—TYMS—lung cancer	2.15e-05	0.000206	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTM1—lung cancer	2.12e-05	0.000203	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.12e-05	0.000203	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CD—lung cancer	2.11e-05	0.000202	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1A1—lung cancer	2.1e-05	0.000201	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—lung cancer	2.08e-05	0.0002	CbGpPWpGaD
Furosemide—CA2—Metabolism—ERCC2—lung cancer	2.08e-05	0.0002	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	2.07e-05	0.000198	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	2.05e-05	0.000197	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	2.05e-05	0.000197	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—lung cancer	2.05e-05	0.000196	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CD—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CD—lung cancer	2.04e-05	0.000196	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—lung cancer	2.03e-05	0.000195	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—lung cancer	2.01e-05	0.000193	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—lung cancer	2.01e-05	0.000193	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1A1—lung cancer	2.01e-05	0.000193	CbGpPWpGaD
Furosemide—CA1—Metabolism—ERCC2—lung cancer	2e-05	0.000191	CbGpPWpGaD
Furosemide—CA12—Metabolism—CREBBP—lung cancer	1.99e-05	0.000191	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAT—lung cancer	1.98e-05	0.000189	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	1.97e-05	0.000189	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD17B10—lung cancer	1.97e-05	0.000189	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APP—lung cancer	1.96e-05	0.000188	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CB—lung cancer	1.96e-05	0.000187	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	1.94e-05	0.000186	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—lung cancer	1.94e-05	0.000186	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—lung cancer	1.92e-05	0.000184	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TF—lung cancer	1.91e-05	0.000183	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CB—lung cancer	1.91e-05	0.000183	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CB—lung cancer	1.91e-05	0.000183	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1A—lung cancer	1.9e-05	0.000182	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—lung cancer	1.9e-05	0.000182	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CD—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Furosemide—CA9—Metabolism—TYMS—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—lung cancer	1.89e-05	0.000181	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	1.88e-05	0.00018	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOA1—lung cancer	1.88e-05	0.00018	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—lung cancer	1.87e-05	0.000179	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—lung cancer	1.87e-05	0.000179	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	1.85e-05	0.000177	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	1.85e-05	0.000177	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CB—lung cancer	1.84e-05	0.000176	CbGpPWpGaD
Furosemide—ALB—Metabolism—CKB—lung cancer	1.83e-05	0.000175	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—lung cancer	1.82e-05	0.000175	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	1.82e-05	0.000174	CbGpPWpGaD
Furosemide—PGD—Disease—EP300—lung cancer	1.81e-05	0.000173	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOA1—lung cancer	1.8e-05	0.000173	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—lung cancer	1.79e-05	0.000171	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—lung cancer	1.78e-05	0.00017	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—lung cancer	1.78e-05	0.00017	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1A1—lung cancer	1.77e-05	0.00017	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—lung cancer	1.76e-05	0.000169	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—lung cancer	1.76e-05	0.000169	CbGpPWpGaD
Furosemide—PGD—Disease—SRC—lung cancer	1.76e-05	0.000169	CbGpPWpGaD
Furosemide—CA9—Metabolism—ERCC2—lung cancer	1.75e-05	0.000168	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—lung cancer	1.73e-05	0.000165	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM2—lung cancer	1.72e-05	0.000165	CbGpPWpGaD
Furosemide—ALB—Metabolism—CNDP2—lung cancer	1.72e-05	0.000165	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—lung cancer	1.72e-05	0.000164	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—lung cancer	1.7e-05	0.000163	CbGpPWpGaD
Furosemide—PGD—Disease—NRAS—lung cancer	1.69e-05	0.000162	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—lung cancer	1.69e-05	0.000162	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTMR3—lung cancer	1.67e-05	0.00016	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	1.67e-05	0.00016	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	1.65e-05	0.000158	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—lung cancer	1.64e-05	0.000158	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—lung cancer	1.63e-05	0.000156	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—lung cancer	1.63e-05	0.000156	CbGpPWpGaD
Furosemide—ALB—Metabolism—PGAM1—lung cancer	1.63e-05	0.000156	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	1.62e-05	0.000156	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK3—lung cancer	1.62e-05	0.000155	CbGpPWpGaD
Furosemide—CA14—Metabolism—EP300—lung cancer	1.61e-05	0.000154	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.59e-05	0.000153	CbGpPWpGaD
Furosemide—CA4—Metabolism—CREBBP—lung cancer	1.59e-05	0.000152	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—lung cancer	1.59e-05	0.000152	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	1.58e-05	0.000152	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—lung cancer	1.58e-05	0.000151	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—lung cancer	1.58e-05	0.000151	CbGpPWpGaD
Furosemide—CA5A—Metabolism—EP300—lung cancer	1.57e-05	0.00015	CbGpPWpGaD
Furosemide—CA6—Metabolism—EP300—lung cancer	1.57e-05	0.00015	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGB1—lung cancer	1.57e-05	0.00015	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—lung cancer	1.57e-05	0.00015	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2A7—lung cancer	1.55e-05	0.000149	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—lung cancer	1.54e-05	0.000148	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	1.54e-05	0.000148	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—lung cancer	1.54e-05	0.000147	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—lung cancer	1.54e-05	0.000147	CbGpPWpGaD
Furosemide—CA2—Metabolism—CREBBP—lung cancer	1.52e-05	0.000146	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDC4—lung cancer	1.52e-05	0.000146	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—lung cancer	1.52e-05	0.000145	CbGpPWpGaD
Furosemide—PGD—Metabolism—EP300—lung cancer	1.51e-05	0.000145	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—lung cancer	1.51e-05	0.000144	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—lung cancer	1.5e-05	0.000144	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	1.49e-05	0.000143	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—lung cancer	1.49e-05	0.000143	CbGpPWpGaD
Furosemide—CA5B—Metabolism—EP300—lung cancer	1.47e-05	0.00014	CbGpPWpGaD
Furosemide—CA7—Metabolism—EP300—lung cancer	1.47e-05	0.00014	CbGpPWpGaD
Furosemide—CA1—Metabolism—CREBBP—lung cancer	1.46e-05	0.00014	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—lung cancer	1.46e-05	0.00014	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	1.46e-05	0.000139	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—lung cancer	1.45e-05	0.000139	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—lung cancer	1.43e-05	0.000137	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—lung cancer	1.42e-05	0.000136	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.39e-05	0.000134	CbGpPWpGaD
Furosemide—ALB—Metabolism—RRM1—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTA3—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—lung cancer	1.39e-05	0.000133	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—lung cancer	1.37e-05	0.000131	CbGpPWpGaD
Furosemide—CA12—Metabolism—EP300—lung cancer	1.36e-05	0.00013	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	1.35e-05	0.000129	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—lung cancer	1.34e-05	0.000128	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.32e-05	0.000127	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—lung cancer	1.32e-05	0.000126	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—lung cancer	1.31e-05	0.000126	CbGpPWpGaD
Furosemide—ALB—Metabolism—B4GALT5—lung cancer	1.3e-05	0.000125	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—lung cancer	1.3e-05	0.000125	CbGpPWpGaD
Furosemide—CA9—Metabolism—CREBBP—lung cancer	1.28e-05	0.000123	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.28e-05	0.000123	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.27e-05	0.000122	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTA4—lung cancer	1.27e-05	0.000121	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—lung cancer	1.26e-05	0.000121	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—lung cancer	1.25e-05	0.00012	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.24e-05	0.000119	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—lung cancer	1.24e-05	0.000119	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.24e-05	0.000119	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTA2—lung cancer	1.24e-05	0.000118	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—lung cancer	1.22e-05	0.000117	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—lung cancer	1.22e-05	0.000117	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—lung cancer	1.21e-05	0.000116	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—lung cancer	1.2e-05	0.000115	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—lung cancer	1.2e-05	0.000115	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—lung cancer	1.19e-05	0.000114	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTA1—lung cancer	1.19e-05	0.000114	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—lung cancer	1.18e-05	0.000114	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCC3—lung cancer	1.18e-05	0.000113	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.17e-05	0.000112	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—lung cancer	1.17e-05	0.000112	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—lung cancer	1.16e-05	0.000111	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—lung cancer	1.16e-05	0.000111	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKR1C1—lung cancer	1.14e-05	0.000109	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—lung cancer	1.14e-05	0.000109	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—lung cancer	1.12e-05	0.000107	CbGpPWpGaD
Furosemide—ALB—Metabolism—UGT1A1—lung cancer	1.11e-05	0.000106	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—lung cancer	1.09e-05	0.000105	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—lung cancer	1.09e-05	0.000104	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—lung cancer	1.08e-05	0.000104	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—lung cancer	1.08e-05	0.000104	CbGpPWpGaD
Furosemide—CA4—Metabolism—EP300—lung cancer	1.08e-05	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNG11—lung cancer	1.07e-05	0.000102	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—lung cancer	1.07e-05	0.000102	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.06e-05	0.000102	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—lung cancer	1.06e-05	0.000102	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EGF—lung cancer	1.05e-05	0.000101	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—lung cancer	1.05e-05	0.000101	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—lung cancer	1.04e-05	0.0001	CbGpPWpGaD
Furosemide—CA2—Metabolism—EP300—lung cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDOA—lung cancer	1.02e-05	9.75e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.01e-05	9.69e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—lung cancer	1e-05	9.63e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—EP300—lung cancer	9.95e-06	9.54e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CREBBP—lung cancer	9.88e-06	9.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NCOA3—lung cancer	9.88e-06	9.46e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—lung cancer	9.74e-06	9.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.7e-06	9.3e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	9.66e-06	9.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADCY1—lung cancer	9.61e-06	9.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG2—lung cancer	9.61e-06	9.21e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—lung cancer	9.49e-06	9.09e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—lung cancer	9.49e-06	9.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HPGDS—lung cancer	9.42e-06	9.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO2—lung cancer	9.42e-06	9.03e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—lung cancer	9.37e-06	8.98e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP2R1B—lung cancer	9.36e-06	8.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.24e-06	8.85e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—lung cancer	9.18e-06	8.79e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—lung cancer	9.15e-06	8.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—lung cancer	9.14e-06	8.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCLC—lung cancer	9.03e-06	8.66e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2A6—lung cancer	9.03e-06	8.66e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9e-06	8.62e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—lung cancer	8.86e-06	8.49e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—lung cancer	8.86e-06	8.49e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—EP300—lung cancer	8.75e-06	8.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO1—lung cancer	8.56e-06	8.21e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	8.56e-06	8.2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.53e-06	8.18e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAF1—lung cancer	8.37e-06	8.02e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—lung cancer	8.21e-06	7.86e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—lung cancer	8.17e-06	7.83e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—lung cancer	8.01e-06	7.68e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	7.89e-06	7.56e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—lung cancer	7.68e-06	7.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2E1—lung cancer	7.68e-06	7.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NQO1—lung cancer	7.59e-06	7.28e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—lung cancer	7.5e-06	7.19e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.44e-06	7.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.37e-06	7.06e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—lung cancer	7.36e-06	7.06e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.24e-06	6.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—STK11—lung cancer	6.85e-06	6.56e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EP300—lung cancer	6.73e-06	6.45e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SRC—lung cancer	6.55e-06	6.27e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—lung cancer	6.54e-06	6.27e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—lung cancer	6.47e-06	6.2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.43e-06	6.16e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—lung cancer	6.37e-06	6.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—lung cancer	6.33e-06	6.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NRAS—lung cancer	6.3e-06	6.03e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—lung cancer	6.27e-06	6.01e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAT—lung cancer	6.16e-06	5.91e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.13e-06	5.87e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK3—lung cancer	6.03e-06	5.78e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—lung cancer	6.02e-06	5.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—lung cancer	6e-06	5.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TYMS—lung cancer	5.89e-06	5.64e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—lung cancer	5.82e-06	5.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1A1—lung cancer	5.52e-06	5.29e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ERCC2—lung cancer	5.47e-06	5.24e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—lung cancer	5.42e-06	5.19e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—lung cancer	5.29e-06	5.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—lung cancer	4.98e-06	4.77e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—lung cancer	4.82e-06	4.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—lung cancer	4.73e-06	4.54e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—lung cancer	4.61e-06	4.41e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.53e-06	4.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—lung cancer	4.32e-06	4.14e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—lung cancer	4.11e-06	3.94e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—lung cancer	4.07e-06	3.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CREBBP—lung cancer	4.01e-06	3.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—lung cancer	3.8e-06	3.64e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—lung cancer	3.31e-06	3.17e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—lung cancer	3.28e-06	3.14e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—lung cancer	2.86e-06	2.74e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—EP300—lung cancer	2.73e-06	2.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—lung cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—lung cancer	1.65e-06	1.58e-05	CbGpPWpGaD
